Aug 6
|
Bio-Techne beats quarterly estimates, flags tariff uncertainty for customers
|
Aug 5
|
Danaher Insiders Sold US$250m Of Shares Suggesting Hesitancy
|
Aug 1
|
Buy Graham Holdings Stock. Its Parts Are Worth More Than the Whole.
|
Aug 1
|
Markel's Q2 Earnings Surpass Estimates, Premiums Rise Y/Y
|
Jul 31
|
Danaher Appoints Jonathan Leiken as General Counsel
|
Jul 28
|
Veralto lifts annual profit forecast on water treatment demand
|
Jul 28
|
International Markets and Danaher (DHR): A Deep Dive for Investors
|
Jul 26
|
Danaher Corporation (DHR)’s Been A Disaster, Says Jim Cramer
|
Jul 25
|
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
|
Jul 25
|
1 S&P 500 Stock with Competitive Advantages and 2 We Turn Down
|
Jul 24
|
Contract research firms' strong earnings signal stabilizing biotech, pharma spending
|
Jul 24
|
CVS or DHR: Which Is the Better Value Stock Right Now?
|
Jul 23
|
Here's Why Danaher (DHR) is a Strong Growth Stock
|
Jul 23
|
Thermo Fisher flags improving tariff situation, raises annual profit view
|
Jul 23
|
Danaher Corp (DHR) Q2 2025 Earnings Call Highlights: Strong Cash Flow and Bioprocessing Growth ...
|
Jul 22
|
Danaher Lifts 2025 Earnings Outlook Amid Biotech Growth, Cost Discipline
|
Jul 22
|
Steven Cohen's Strategic Moves: A Closer Look at Danaher Corp's Impact on His Portfolio
|
Jul 22
|
Danaher Q2 Earnings Beat Estimates, Life Sciences Sales Up Y/Y
|
Jul 22
|
Danaher (DHR) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
|
Jul 22
|
Stocks Down Pre-Bell Ahead of Key Earnings, Fed Chair Powell's Speech
|